|
PAX2 Transcription Factor
|
D12.776.930.700.750 |
|
|
Streptococcus suis
|
B03.510.550.737.872.750 |
|
|
Luteovirus
|
B04.820.578.469.500 |
|
|
Luteoviridae
|
B04.820.578.469 |
|
|
Propylene Glycol
|
D019946 |
[A clear, colorless, viscous organic solvent and diluent used in pharmaceutical preparations.
] |
|
Genes, bcl-1
|
D019940 |
[The B-cell leukemia/lymphoma-1 genes, associated with various neoplasms when overexpressed. Overexpression results from the t(11;14) translocation, which is characteristic of mantle zone-derived B-cell lymphomas. The human c-bcl-1 gene is located at 11q13 on the long arm of chromosome 11.
] |
|
Cyclin-Dependent Kinase Inhibitor p16
|
D019941 |
[A product of the p16 tumor suppressor gene (GENES, P16). It is also called INK4 or INK4A because it is the prototype member of the INK4 CYCLIN-DEPENDENT KINASE INHIBITORS. This protein is produced from the alpha mRNA transcript of the p16 gene. The other gene product, produced from the alternatively spliced beta transcript, is TUMOR SUPPRESSOR PROTEIN P14ARF. Both p16 gene products have tumor suppressor functions.
] |
|
Genes, p16
|
D019942 |
[Tumor suppressor genes located on human chromosome 9 in the region 9p21. This gene is either deleted or mutated in a wide range of malignancies. (From Segen, Current Med Talk, 1995) Two alternatively spliced gene products are encoded by p16: CYCLIN-DEPENDENT KINASE INHIBITOR P16 and TUMOR SUPPRESSOR PROTEIN P14ARF.
] |
|
Glucagon-Like Peptide-1 Receptor
|
D000067757 |
[A receptor for GLUCAGON-LIKE PEPTIDE 1 (GLP-1) expressed primarily on the surface of beta and ductal exocrine cells of the pancreas, as well as cells of other tissues. GLP-1 acts through GLP-1R to potentiate signaling in pancreatic cells in response to glucose-stimulated insulin secretion (GSIS).
] |
|
Glucagon-Like Peptide-2 Receptor
|
D000067758 |
[A receptor for GLUCAGON-LIKE PEPTIDE 2 (GLP-2) that is expressed on the surface of intestinal cells as well as neural cells. GLP-2 and other peptides act through GLP-2R to regulate cellular responses to BLOOD GLUCOSE, INFLAMMATION, and FOOD INTAKE.
] |
|
Receptor for Advanced Glycation End Products
|
D000067759 |
[A single-pass transmembrane CELL SURFACE RECEPTOR that binds ADVANCED GLYCATION END PRODUCTS to mediate cellular responses to both acute and chronic vascular inflammation in conditions such as ATHEROSCLEROSIS and DIABETES MELLITUS, TYPE 2. It also binds AMYLOID BETA PEPTIDES; ALARMINS; S100A12 PROTEIN and S100 CALCIUM BINDING PROTEIN BETA SUBUNIT.
] |
|
Elimination Disorders
|
D019960 |
[Excretory-related psychiatric disorders usually diagnosed in infancy or childhood.
] |
|
Castration
|
E04.950.165 |
|
|
Fetal Growth Retardation
|
D005317 |
[Failure of a FETUS to attain expected GROWTH.
] |
|
Fetal Heart
|
D005318 |
[The heart of the fetus of any viviparous animal. It refers to the heart in the postembryonic period and is differentiated from the embryonic heart (HEART/embryology) only on the basis of time.
] |
|
Fetal Hemoglobin
|
D005319 |
[The major component of hemoglobin in the fetus. This HEMOGLOBIN has two alpha and two gamma polypeptide subunits in comparison to normal adult hemoglobin, which has two alpha and two beta polypeptide subunits. Fetal hemoglobin concentrations can be elevated (usually above 0.5%) in children and adults affected by LEUKEMIA and several types of ANEMIA.
] |
|
Sesame Oil
|
D20.215.784.750.865 |
|
|
Glucagon-Like Peptide Receptors
|
D000067756 |
[G-PROTEIN COUPLED CELL SURFACE RECEPTORS that bind GLUCAGON-LIKE PEPTIDES and are expressed by cells in pancreatic, intestinal, and neural tissues. These receptors regulate cellular responses to BLOOD GLUCOSE, INSULIN, and INFLAMMATION signals.
] |
|
Fetal Death
|
D005313 |
[Death of the developing young in utero. BIRTH of a dead FETUS is STILLBIRTH.
, Drying and shriveling of the fetus that sometimes occurs after the resorption of fluid following fetal death in veterinary animals.
] |
|
Single-Parent Family
|
D020954 |
[A household that includes children and is headed by one adult.
] |
